The 64th American Society of Hematology (ASH) meeting is being held between 10 and 13 December in New Orleans, Louisiana. In this context, Twitter influencer conversations around the malignant and classical hematology event surged in the second week of December. Subsequently, the Social Media Analytics Platform of GlobalData, a leading data and analytics company, has come up with the top 10 influencers on #ASH22 on Twitter, based on Global Scores.
Global Score is the measure of the influence of a Twitter contributor, which is calculated using the average engagements received on content shared, number of followers, and number of times other influencers have referred him/her in their shared content.
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Fransisco (UCSF) has emerged as the top influencer on #ASH22. Prasad is also a writer and author of many academic articles. ‘Malignant’ and ‘Medical Reversal’ are two of his published books. He also runs a lab at UCSF, which studies various clinical trials, cancer drugs, and health policies. He has tweeted 31 posts on #ASH22 so far and received total engagements of more than 8,100, which include likes and retweets.

Below are a few popular tweets of Vinay Prasad on #ASH22:
“Medical conferences would be more fun if it was a 4 day tournament. With winning abstracts advancing each day. So the last day is just the 10-20 best talks. #Ash22”
196 Likes, 12 RTs
59 Likes, 9 RTs
Angela Christine Weyand, with a Global Score of 98, is the next top influencer. Weyand is the Clinical Associate Professor at C.S. Mott Children’s Hospital and has a specialty in pediatric hematology or oncology. She has shared 41 posts on the #ASH22 event.
Below is her most engaging post:
124 Likes, 22 RTs
The remaining top 10 positions were occupied by Aaron Goodman, Vincent Rajkumar, Tatiana Prowell, Adam Feuerstein, David Steensma, Kamran Mirza, Navneet Majhail, and Mike Thompson.
Smitarani Tripathy, Social Media Analyst at GlobalData, comments: “The drugs with the most mentions among influencer discussions during #ASH22 are Ibrutinib, Venetoclax, Lenalidomide, and Carfilzomib. The discussion around Ibrutinib was related to how this can replace stem cells transplantation as first-line treatment of Mantle Cell Lymphoma.”